Comparative Analysis of Commercial Kit versus In-House Protocol for Assessing Endodermal Differentiation Potential in Human Embryonic Stem Cells.

Résumé fourni par la source

Objective: Human embryonic stem cells (hESCs) have the capacity to differentiate into all cell lineages, making them invaluable for cell-based therapies. However, the ability of individual hESC lines to generate the three embryonic germ layers varies. Selecting a cell line with a high propensity for definitive endoderm (DE) differentiation is crucial for producing pancreatic progenitors, hepatocytes, and other endodermal derivatives. Direct and spontaneous differentiation are two commonly used methods to assess hESC differentiation potential; both are complex and time-consuming. This study evaluates a commercially available differentiation kit as a simple and reproducible screening assay to predict the DE differentiation potential of various hESC lines. Materials and Methods: In this experimental study, three hESC lines obtained from the Royan Institute Stem Cell Bank (Tehran, Iran) were used. Pluripotency was confirmed by evaluating cell morphology, OCT4 protein expression, and alkaline phosphatase staining. Early-stage lineage differentiation was compared between the StemMACS™ Trilineage kit and a previously established DE protocol. Differentiation outcomes were assessed using gene and protein expression analyses, including flow cytometry, quantitative real-time polymerase chain reaction (qRT-PCR), and immunostaining. Results: The three hESC lines exhibited varying capacities for DE differentiation. Flow cytometry analysis of the surface marker CXCR4 showed differentiation efficiencies of 70% for RH2, compared with 35% and 40% for RH5 and RH6, respectively. The superior efficiency of RH2 was consistent across both differentiation protocols, as evidenced by its strong CXCR4 expression using the in-house method. Conclusion: hESC lines exhibit variable capacities for differentiation. Commercial kit-based screening provides a simple and reliable method to identify suitable hESC lines for generating endoderm-derived cells.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.